Rockefeller University: Rogue Enzymes Cause Numerous Diseases, A New Method Could Help Design Drugs to Treat Them
March 08, 2024
March 08, 2024
NEW YORK, March 8 (TNSres) -- Rockefeller University issued the following news:
Helicases are enzymes that unwind DNA and RNA. They're central to cellular life, implicated in a number of cancers and infections--and, alas, extraordinarily difficult to target with drugs.
Now, new research provides a powerful platform for designing covalent inhibitors tailored to target helicases. The paper, published in the Journal of the American Chemical Society, describes how research . . .
Helicases are enzymes that unwind DNA and RNA. They're central to cellular life, implicated in a number of cancers and infections--and, alas, extraordinarily difficult to target with drugs.
Now, new research provides a powerful platform for designing covalent inhibitors tailored to target helicases. The paper, published in the Journal of the American Chemical Society, describes how research . . .